Sign inGet started

NIES ALAN S

Insider CIK 1270260 · LXRX Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
LXRX LEXICON PHARMACEUTICALS, I M Exercise deriv2023-05-212023-05-229,302— $00SEC↗
LXRX LEXICON PHARMACEUTICALS, I M Exercise2023-05-212023-05-229,302— $041,046SEC↗
LXRX LEXICON PHARMACEUTICALS, I A Award deriv2023-04-282023-04-288,032— $08,032SEC↗
LXRX LEXICON PHARMACEUTICALS, I A Award deriv2023-04-282023-04-2812,658— $012,658SEC↗
LXRX LEXICON PHARMACEUTICALS, I A Award deriv2022-05-212022-05-2314,402— $014,402SEC↗
LXRX LEXICON PHARMACEUTICALS, I A Award deriv2022-05-212022-05-239,302— $09,302SEC↗
LXRX LEXICON PHARMACEUTICALS, I M Exercise deriv2022-04-302022-05-024,024— $00SEC↗
LXRX LEXICON PHARMACEUTICALS, I M Exercise2022-04-302022-05-024,024— $031,744SEC↗
LXRX LEXICON PHARMACEUTICALS, I A Award deriv2021-04-302021-05-036,475— $06,475SEC↗
LXRX LEXICON PHARMACEUTICALS, I A Award deriv2021-04-302021-05-034,024— $04,024SEC↗
LXRX LEXICON PHARMACEUTICALS, I M Exercise deriv2021-04-242021-04-2710,638— $00SEC↗
LXRX LEXICON PHARMACEUTICALS, I M Exercise2021-04-242021-04-2710,638— $027,720SEC↗
LXRX LEXICON PHARMACEUTICALS, I M Exercise deriv2020-04-262020-04-273,466— $00SEC↗
LXRX LEXICON PHARMACEUTICALS, I M Exercise2020-04-262020-04-273,466— $017,082SEC↗
LXRX LEXICON PHARMACEUTICALS, I A Award deriv2020-04-242020-04-2718,115— $018,115SEC↗
LXRX LEXICON PHARMACEUTICALS, I A Award deriv2020-04-242020-04-2710,638— $010,638SEC↗
LXRX LEXICON PHARMACEUTICALS, I A Award deriv2019-04-262019-04-296,519— $06,519SEC↗
LXRX LEXICON PHARMACEUTICALS, I A Award deriv2019-04-262019-04-293,466— $03,466SEC↗
LXRX LEXICON PHARMACEUTICALS, I A Award deriv2018-04-272018-04-272,857— $02,857SEC↗
LXRX LEXICON PHARMACEUTICALS, I A Award2018-04-272018-04-272,564— $013,616SEC↗
LXRX LEXICON PHARMACEUTICALS, I A Award deriv2017-04-282017-05-012,857— $02,857SEC↗
LXRX LEXICON PHARMACEUTICALS, I A Award2017-04-282017-05-011,281— $011,052SEC↗
LXRX LEXICON PHARMACEUTICALS, I A Award deriv2016-04-292016-05-022,857— $02,857SEC↗
LXRX LEXICON PHARMACEUTICALS, I A Award2016-04-292016-05-021,432— $09,771SEC↗
LXRX LEXICON PHARMACEUTICALS, I A Award deriv2015-04-242015-04-2420,000— $020,000SEC↗
LXRX LEXICON PHARMACEUTICALS, I A Award2015-04-242015-04-2418,691— $058,376SEC↗
LXRX LEXICON PHARMACEUTICALS, I A Award deriv2014-04-252014-04-2920,000— $020,000SEC↗
LXRX LEXICON PHARMACEUTICALS, I A Award2014-04-252014-04-2912,820— $039,685SEC↗
LXRX LEXICON PHARMACEUTICALS, I A Award deriv2013-05-102013-05-1320,000— $020,000SEC↗
LXRX LEXICON PHARMACEUTICALS, I A Award2013-05-102013-05-1310,101— $026,865SEC↗
LXRX LEXICON PHARMACEUTICALS, I A Award deriv2012-04-272012-04-2720,000— $020,000SEC↗
LXRX LEXICON PHARMACEUTICALS, I A Award2012-04-272012-04-2711,764— $016,764SEC↗